Research Article
Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
Table 2
Procedural adverse clinical outcomes stratified by the presence of concomitant coronary artery disease (CAD).
| | Whole population | CAD group | No CAD group | value CAD versus no CAD | N = 1030 | N = 372 | N = 658 |
| Death, N(%) | 28 (2.7) | 11 (3) | 17 (2.6) | 0.72 |
| Significant complications, N(%) | Major or life-threatening bleeding | 29 (2.8) | 14 (3.8) | 15 (2.3) | 0.16 | Minor bleeding | 37 (3.6) | 14 (3.8) | 23 (3.5) | 0.82 | Major vascular complication | 40 (3.9) | 17 (4.6) | 23 (3.5) | 0.39 | Minor vascular complication | 77 (7.5) | 25 (6.7) | 52 (7.9) | 0.48 | Stroke | 25 (2.4) | 9 (2.4) | 16 (2.4) | 0.99 | Acute kidney injury | 28 (2.7) | 8 (2.2) | 20 (3) | 0.39 | Pacemaker implantation | 129 (12.5) | 51 (13.7) | 78 (11.9) | 0.38 |
| CCU admission, N(%) | 567 (55) | 212 (57) | 355 (54) | 0.34 |
|
|